From Chemical Biology to Clinical Candidate Selection: Addressing Key Challenges in the Development of A2A Receptor NAMs for Cancer Immunotherapy

Prof. Leonardo Scapozza, University Geneva, Switzerland

Veranstaltung übernehmen als iCal